OSA and COPD present with symptoms that often go undetected for too long. How can clinicians recognize symptoms faster?

Patients with COPD or interstitial lung disease who partook in a weekly online group singing program reported improved ...

At the European Respiratory Society Congress 2025, Lucilla Piccari, MD, PhD, a pulmonologist at Hospital del Mar in Barcelona ...

Research reveals strong connections between muscle strength and cognitive function in patients with COPD, highlighting the potential for rehabilitation strategies.

An expert discusses how the IMpower133 trial established atezolizumab plus chemotherapy as standard care for extensive-stage ...

Clinical benefit for efzofitimod across multiple disease-related health outcomes reported.Improvement in Fatigue Assessment Scale Total Score at ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...

Zelasudil, a potential best-in-class, selective ROCK2 inhibitor shows evidence of anti-fibrotic activity at 12 and 24 weeks in patients with IPFZelasudil reduces FVC decline numerically at 12 weeks ...

CHEST 2025 Posters, Oral Session and Learning Theater Oral Presentation Title: Efficacy of Inhaled Molgramostim According to Severity of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Session Title: ...

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease associated with poor quality of ...

Individuals with post-COVID syndrome had higher immune cell counts after receiving exercise-based rehabilitation vs. usual care for 8 weeks, according to data presented at the European Respiratory ...